Cisplatin
Orphan DrugFDA Approved
Description
Cisplatin is a platinum-based chemotherapy agent that forms DNA crosslinks, inhibiting DNA replication and transcription. It has orphan drug designation for treatment of rare malignancies including pulmonary blastoma. The drug is typically used in combination chemotherapy regimens for various solid tumors.
Indications & Therapeutic Use
Testicular cancer, ovarian cancer, bladder cancer, lung cancer, pulmonary blastoma
Linked Diseases:
pulmonary blastoma
D018202
Global Availability (9 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Cisplatin
| Generic Name | Cisplatin |
| Brands | 1 brand available |
| Active Ingredient | Cisplatin |
| Drug Class | Testicular cancer |
| Manufacturer | Bristol-Myers Squibb |
| Dosage Forms | IV infusion 1mg/mL |
| Medical Code | L01XA01 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00003299 |
| Countries | 9 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations10 Validated Nodes